Your browser doesn't support javascript.
loading
Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients.
D'Huyvetter, Matthias; Vos, Jens De; Caveliers, Vicky; Vaneycken, Ilse; Heemskerk, Johannes; Duhoux, Francois P; Fontaine, Christel; Vanhoeij, Marian; Windhorst, Albert D; Aa, Frank van der; Hendrikse, N Harry; Eersels, Jos L E; Everaert, Hendrik; Gykiere, Pieterjan; Devoogdt, Nick; Raes, Geert; Lahoutte, Tony; Keyaerts, Marleen.
Affiliation
  • D'Huyvetter M; Precirix NV/SA, Brussels, Belgium; marleen.keyaerts@vub.be.
  • Vos J; In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium.
  • Caveliers V; Precirix NV/SA, Brussels, Belgium.
  • Vaneycken I; In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium.
  • Heemskerk J; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium.
  • Duhoux FP; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium.
  • Fontaine C; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium.
  • Vanhoeij M; Medical Oncology Department, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc and Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
  • Windhorst AD; Department of Medical Oncology, UZ Brussel, Brussels, Belgium.
  • Aa FV; Department of Oncological Surgery, UZ Brussel, Brussels, Belgium.
  • Hendrikse NH; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Eersels JLE; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Everaert H; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Gykiere P; Precirix NV/SA, Brussels, Belgium.
  • Devoogdt N; In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Brussels, Belgium.
  • Raes G; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium.
  • Lahoutte T; Nuclear Medicine Department, UZ Brussel, Brussels, Belgium.
  • Keyaerts M; Precirix NV/SA, Brussels, Belgium.
J Nucl Med ; 62(8): 1097-1105, 2021 08 01.
Article in En | MEDLINE | ID: mdl-33277400
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans / Middle aged Language: En Journal: J Nucl Med Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans / Middle aged Language: En Journal: J Nucl Med Year: 2021 Document type: Article Country of publication: